Effects of RME on Engagement in Buprenorphine Treatment (NCT05184907) | Clinical Trial Compass
CompletedNot Applicable
Effects of RME on Engagement in Buprenorphine Treatment
United States25 participantsStarted 2022-05-01
Plain-language summary
The investigators will conduct a Randomized Controlled Trial (RCT) comparing the Remote Motivational Enhancement (RME) coaching sessions + MindWell screenings arm to an Information-only + MindWell screenings arm on early engagement in treatment support services, as measured by overall action plan initiation.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 or older
* Meets DSM-IV criteria for opioid dependence or DSM-V criteria for opioid use disorder
* Current patient enrolled in Bicycle Health's buprenorphine treatment program
* Ability to provide informed consent
* Access to the internet and an electronic device to attend remote coaching sessions via videoconferencing and complete online assessments
* Sufficient English fluency to understand study procedures and assessments
* Completion of the CAT-MH screening modules, BAM, and PSS measures (through CHAMindWell and Bicycle Health's service implementation project)
Exclusion Criteria:
* Non-English speaking
* Reporting active homicidal or suicidal ideation
* Exhibits signs of active mania or psychosis
* Expected incarceration in next 12 weeks (those that are incarcerated during the study will be withdrawn from the study)
* Prisoners
* Unable or unwilling to use a mobile device
* Has a medical contraindication to BUP
* Unable to complete screening and baseline assessments
* Unstable medical illness that could lead to an expected hospitalization in the next 12 weeks
* Third-trimester pregnancy (if a pregnant participant plans to deliver within 12 weeks of study consent)